Bernard "Barry" Sherman: Apotex founder, businessman and philanthropist

Business career and Apotex

Sherman founded Apotex in the 1970s and guided its growth into a multinational manufacturer of generic pharmaceuticals. Under his leadership the company expanded production, exported internationally and frequently challenged patent assertions by brand-name drug makers. Apotex was a central player in debates about access to affordable medicines and the regulation of generics, and its approach often led to high-profile legal and commercial disputes.

Philanthropy and public activity

Alongside his business activities, Sherman was an active philanthropist. He and his family supported hospitals, medical research, educational institutions and community organisations, including Jewish and civic causes. His donations funded research programs, capital projects and initiatives aimed at improving health care and education. His public recognition included national honours and frequent media coverage of both his business success and charitable giving.

Death and investigation

On December 15, 2017, police discovered the bodies of Sherman and his wife at their home in North York, Toronto. Authorities initially reported that the couple were found deceased at their residence; the home location and context were widely reported in local and national media, including links to coverage of the neighbourhood where they lived (North York) and the city of Toronto). Post-mortem examinations reported the cause of death as ligature neck compression. The circumstances prompted speculation and competing theories, including family statements rejecting a murder–suicide explanation.

Police response and public reaction

The deaths drew intensive police investigation and international media attention. Toronto police described the deaths as suspicious and later treated them as homicides; the case generated considerable public interest because of the Shermans’ prominence. Coverage of Sherman's fortune and status among Canada’s wealthiest people appeared in business reporting and rankings (see reporting by business outlets), and the combination of his public profile and the unusual circumstances of the deaths led to ongoing scrutiny.

Legacy and notable aspects

Sherman’s legacy is multifaceted: he is remembered for building a major Canadian pharmaceutical company, for philanthropic support of health and education, and for the unresolved questions surrounding his and his wife’s deaths. The events surrounding the couple’s passing prompted legal inquiries, media investigations and public debate about corporate governance, personal security of high-profile business figures, and the process of police investigations in high-profile cases.

• Founder and long-time leader of Apotex, a leading Canadian generics manufacturer.
• Recognised philanthropist supporting medical research, hospitals and educational programs.
• Death in 2017 led to a high-profile police inquiry and widespread media coverage; see contemporary reporting and official statements for updates (biography, business reports).